Learn About Central Serous Chorioretinopathy
- Central serous chorioretinopathy
- Central serous chorioretinopathy after bone marrow transplantation
- Central serous choroidopathy
Vitreous Retina Macula Consultants Of New York
Lawrence Yannuzzi is an Ophthalmologist in New York, New York. Dr. Yannuzzi and is rated as an Elite provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.
Vitreous Retina Macula Consultants Of New York(Downtown)
Richard Spaide is an Ophthalmologist in New York, New York. Dr. Spaide and is rated as an Elite provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Central Serous Chorioretinopathy, and Vitrectomy.
University Of Pittsburgh Physicians
Jay Chhablani is an Ophthalmologist in Bethel Park, Pennsylvania. Dr. Chhablani and is rated as an Elite provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Central Serous Chorioretinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.
Summary: To investigate the potential association between gut microbiota and central serous chorioretinopathy (CSC), we have observed in our clinical practice that CSC patients often experience chronic gastrointestinal issues. This observation has led us to hypothesize that CSC may be associated with gut dysbiosis. The Bifidobacterium genus is widely recognized as a beneficial gut bacterium, and numerous w...
Summary: This is a prospective, multicentre, sham-controlled, participant- and assessor-masked superiority trial with two parallel treatment arms which aims to investigate the safety and efficacy of subthreshold nanosecond laser (SNL) in a series of adults with sub-retinal fluid secondary to non-resolving central serous chorioretinopathy (CSCR) by visual and anatomical outcomes. The study population will b...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center